Organovo Holdings, Inc. (NASDAQ:ONVO) shares are trading higher Monday after the company announced Phase 2 results for FXR314 ...

The canary in the EV coal mine has had a great run, but it’s running out of oxygen.More From InvestorPlace The #1 AI ...

Just to start things off, could you tell us a bit about what Organovo Holdings does? Mr. Murphy: Absolutely. Organovo is advancing a first-in-class FXR agonist for IBD. FXR agonists haven’t been ...

Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced ...

Organovo Holdings said on Monday its experimental drug to treat a type of fatty liver disease helped significantly reduce liver fat in a mid-stage study.

CETArcelorMittal (‘the Company’) today announces the publication of its first quarter 2024 sell-side analyst consensus ...

Based on NIO's lower highs and lower lows over the past few quarters, it appears that the bears may have temporarily won the ...

These establishments in Monroe County were inspected between April 1 and 7, according to Pennsylvania Department of ...

BrandShield, which shared this information exclusively with Reuters, said that out of the 279 pharmacy websites the company closed last year for selling drugs intended to treat metabolic conditions, ...